These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
203 related articles for article (PubMed ID: 35850434)
1. Statins and angiogenesis in non-cardiovascular diseases. Zahedipour F; Butler AE; Rizzo M; Sahebkar A Drug Discov Today; 2022 Oct; 27(10):103320. PubMed ID: 35850434 [TBL] [Abstract][Full Text] [Related]
2. Pleiotropic properties of statins via angiogenesis modulation in cardiovascular disease. Zahedipour F; Butler AE; Eid AH; Sahebkar A Drug Discov Today; 2022 Oct; 27(10):103325. PubMed ID: 35872297 [TBL] [Abstract][Full Text] [Related]
3. Diverse effects of statins on angiogenesis: new therapeutic avenues. Elewa HF; El-Remessy AB; Somanath PR; Fagan SC Pharmacotherapy; 2010 Feb; 30(2):169-76. PubMed ID: 20099991 [TBL] [Abstract][Full Text] [Related]
4. The HMG-CoA reductase pathway, statins and angioprevention. Feng C; Han A; Ye C; Xu R; Li M Semin Ophthalmol; 2006; 21(1):29-35. PubMed ID: 16517442 [TBL] [Abstract][Full Text] [Related]
6. Statins have biphasic effects on angiogenesis. Weis M; Heeschen C; Glassford AJ; Cooke JP Circulation; 2002 Feb; 105(6):739-45. PubMed ID: 11839631 [TBL] [Abstract][Full Text] [Related]
7. Statins and cardiovascular diseases: from cholesterol lowering to pleiotropy. Zhou Q; Liao JK Curr Pharm Des; 2009; 15(5):467-78. PubMed ID: 19199975 [TBL] [Abstract][Full Text] [Related]
8. Targeting the mevalonate cascade as a new therapeutic approach in heart disease, cancer and pulmonary disease. Yeganeh B; Wiechec E; Ande SR; Sharma P; Moghadam AR; Post M; Freed DH; Hashemi M; Shojaei S; Zeki AA; Ghavami S Pharmacol Ther; 2014 Jul; 143(1):87-110. PubMed ID: 24582968 [TBL] [Abstract][Full Text] [Related]